These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 28192397

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2.
    You J, Li Y, Fang N, Liu B, Zu L, Chang R, Li X, Zhou Q.
    PLoS One; 2014; 9(3):e91827. PubMed ID: 24626466
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
    Chang TH, Tsai MF, Gow CH, Wu SG, Liu YN, Chang YL, Yu SL, Tsai HC, Lin SW, Chen YW, Kuo PY, Yang PC, Shih JY.
    Cancer Lett; 2017 Aug 28; 402():190-202. PubMed ID: 28610956
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer.
    Xu Q, Sun Q, Zhang J, Yu J, Chen W, Zhang Z.
    Carcinogenesis; 2013 Mar 28; 34(3):539-49. PubMed ID: 23188671
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. miR-338-3p suppresses epithelial-mesenchymal transition and metastasis in human nonsmall cell lung cancer.
    Hong-Yuan W, Xiao-Ping C.
    Indian J Cancer; 2015 Dec 28; 52 Suppl 3():E168-71. PubMed ID: 27453416
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
    Ren D, Wang M, Guo W, Huang S, Wang Z, Zhao X, Du H, Song L, Peng X.
    Cell Tissue Res; 2014 Dec 28; 358(3):763-78. PubMed ID: 25296715
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2, an epithelial-mesenchymal transition regulator.
    Jiao A, Sui M, Zhang L, Sun P, Geng D, Zhang W, Wang X, Li J.
    Mol Med Rep; 2016 Apr 28; 13(4):3349-55. PubMed ID: 26935975
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
    Kurashige J, Kamohara H, Watanabe M, Hiyoshi Y, Iwatsuki M, Tanaka Y, Kinoshita K, Saito S, Baba Y, Baba H.
    Ann Surg Oncol; 2012 Jul 28; 19 Suppl 3():S656-64. PubMed ID: 22311119
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. K-ras mutation promotes ionizing radiation-induced invasion and migration of lung cancer in part via the Cathepsin L/CUX1 pathway.
    Wang L, Zhao Y, Xiong Y, Wang W, Fei Y, Tan C, Liang Z.
    Exp Cell Res; 2018 Jan 15; 362(2):424-435. PubMed ID: 29246726
    [Abstract] [Full Text] [Related]

  • 18. miR-942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer.
    Yang F, Shao C, Wei K, Jing X, Qin Z, Shi Y, Shu Y, Shen H.
    J Cell Physiol; 2019 Dec 15; 234(12):23596-23607. PubMed ID: 31236953
    [Abstract] [Full Text] [Related]

  • 19. MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma.
    Guo F, Cogdell D, Hu L, Yang D, Sood AK, Xue F, Zhang W.
    Oncol Rep; 2014 May 15; 31(5):2021-8. PubMed ID: 24677166
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.